NASDAQ:CYTHW
Cyclo Therapeutics
- Stock
Last Close
0.72
26/03 20:00
Market Cap
39.49M
Beta: -
Volume Today
186.81K
Avg: 2.95K
PE Ratio
−1.53
PFCF: −2.83
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 408.09K - | 592.67K 45.23% | 553.78K 6.56% | 484.31K 12.55% | 443.88K 8.35% | 329.58K 25.75% | 240.27K 27.10% | 232.67K 3.16% | 240.96K 3.56% | 254.42K 5.58% | |
average payables | 171.27K - | 642.79K 275.30% | 1.43M 123.12% | 962.67K 32.88% | 1.74M - | 1.74M 0% | |||||
average receivables | 90.13K - | 68.31K 24.21% | 89.85K 31.53% | 108.40K 20.65% | 105.11K 3.03% | 149.99K 42.69% | 147.14K 1.90% | 325.44K 121.18% | 297.04K 8.73% | 88.69K 70.14% | |
book value per share | 8.65 - | 6.66 22.93% | 2.41 63.85% | 1.59 33.98% | 1.21 23.66% | 0.77 36.58% | 6.54 748.89% | 2.46 62.36% | 0.12 95.31% | 0.29 152.55% | |
capex per share | -0.34 - | -0.75 116.80% | -0.01 98.02% | -0.01 35.46% | -0.00 61.97% | -0.00 69.91% | -0.03 2,950.19% | -0.00 89.37% | -0.00 32.93% | ||
capex to depreciation | -1.14 - | -2.48 117.45% | -0.09 96.48% | -0.74 747.68% | -0.29 60.48% | -0.23 20.26% | -4.16 1,686.07% | -1.34 67.88% | -0.77 42.09% | ||
capex to operating cash flow | 0.28 - | 0.21 23.51% | 0.00 98.50% | 0.00 29.29% | 0.00 58.55% | 0.00 78.35% | 0.01 2,996.08% | 0.00 75.90% | 0.00 33.43% | ||
capex to revenue | -0.11 - | -0.44 297.62% | -0.01 98.59% | -0.01 10.90% | -0.00 47.19% | -0.00 55.07% | -0.06 4,373.77% | -0.01 75.87% | -0.01 22.72% | ||
cash per share | 4.71 - | 3.28 30.40% | 1.52 53.76% | 1.76 16.41% | 2.71 53.72% | 2.29 15.57% | 8.03 250.79% | 2.61 67.53% | 0.24 90.71% | 0.57 133.63% | |
days of inventory on hand | 770.02 - | 1.79K 132.45% | 914.94 48.88% | 1.29K 41.43% | 1.45K 11.87% | 1.17K 18.96% | 1.31K 11.49% | 531.87 59.33% | 668.61 25.71% | 1.10K 64.58% | |
days payables outstanding | 630.09 - | 2.59K 310.99% | 6.69K 158.38% | 9.14K - | |||||||
days sales outstanding | 18.86 - | 21.37 13.30% | 30.13 41.02% | 27.35 9.23% | 42.39 55.01% | 66.13 55.99% | 45.17 31.70% | 124.08 174.72% | 14.59 88.24% | 41.50 184.43% | |
debt to assets | 0.15 - | 0.16 5.44% | 0.01 - | 0.01 7.35% | 0.01 36.08% | 0.08 - | |||||
debt to equity | 0.18 - | 0.20 10.72% | 0.06 - | 0.02 66.84% | 0.01 41.35% | 0.22 - | |||||
dividend yield | |||||||||||
earnings yield | -0.02 - | -0.08 350.42% | -0.16 87.87% | -0.15 1.95% | -0.07 57.21% | -0.19 185.40% | -1.28 590.82% | -0.60 53.06% | -1.69 180.66% | -0.77 54.28% | |
enterprise value | 30.76M - | 29.83M 3.04% | 26.28M 11.88% | 23.94M 8.90% | 63.19M 163.92% | 38.60M 38.91% | -5.70M 114.75% | 7.32M 228.51% | 7.50M 2.47% | 17.75M 136.70% | |
enterprise value over ebitda | -75.05 - | -14.23 81.04% | -8.12 42.90% | -6.25 23.08% | -14.89 138.25% | -5.33 64.21% | 0.64 111.92% | -0.51 180.95% | -0.48 7.42% | -0.89 85.97% | |
ev to operating cash flow | -48.74 - | -14.99 69.24% | -8.91 40.60% | -7.82 12.22% | -19.82 153.50% | -5.86 70.44% | 0.67 111.38% | -0.49 173.14% | -0.50 1.73% | -1.10 121.04% | |
ev to sales | 19.63 - | 31.38 59.90% | 17.49 44.27% | 19.34 10.61% | 62.47 222.96% | 38.32 38.65% | -6.30 116.45% | 4.62 173.21% | 5.45 18.11% | 16.49 202.53% | |
free cash flow per share | -1.59 - | -4.29 169.03% | -4.67 9.04% | -4.26 8.81% | -3.90 8.38% | -5.42 38.89% | -5.37 0.89% | -2.36 56.10% | -2.38 0.71% | -0.99 58.28% | |
free cash flow yield | -0.02 - | -0.08 213.06% | -0.11 39.47% | -0.12 12.03% | -0.05 59.92% | -0.16 226.80% | -1.24 674.66% | -0.63 48.80% | -1.67 164.54% | -0.62 62.74% | |
graham net net | 3.59 - | 2.09 41.61% | 1.51 27.71% | 0.88 41.96% | 0.72 18.10% | -0.11 115.47% | 5.82 5,330.80% | 2.09 64.20% | -0.28 113.32% | 0.06 121.50% | |
graham number | 15.10 - | 26.09 72.72% | 19.01 27.14% | 13.80 27.41% | 11.92 13.59% | 10.46 12.29% | 28.65 173.91% | 11.15 61.08% | 2.50 77.62% | 2.84 13.70% | |
income quality | 1.06 - | 0.78 26.78% | 0.70 10.40% | 0.80 14.36% | 0.75 6.21% | 0.87 16.74% | 0.96 9.18% | 1.05 9.97% | 0.98 6.86% | 0.81 17.51% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -16.70 - | -76.92 360.60% | -147.04 91.17% | 103.76 - | |||||||
interest debt per share | 1.64 - | 1.40 14.73% | 0.05 96.77% | 0.04 - | 0.12 181.47% | 0.03 77.92% | -0.02 188.02% | 0.06 367.78% | |||
inventory turnover | 0.47 - | 0.20 56.98% | 0.40 95.63% | 0.28 29.29% | 0.25 10.61% | 0.31 23.40% | 0.28 10.30% | 0.69 145.89% | 0.55 20.45% | 0.33 39.24% | |
invested capital | 0.18 - | 0.20 10.72% | 0.06 - | 0.02 66.84% | 0.01 41.35% | 0.22 - | |||||
market cap | 32.35M - | 30.92M 4.43% | 27.24M 11.88% | 25.21M 7.45% | 65.41M 159.41% | 41.33M 36.81% | 6.96M 83.17% | 23.76M 241.55% | 9.04M 61.94% | 25.96M 187.13% | |
net current asset value | 2.13M - | 1.51M 29.19% | 1.29M 14.45% | 952.75K 26.31% | 844.28K 11.39% | 780.82K 7.52% | 10.31M 1,221.01% | 15.59M 51.12% | 677.89K 95.65% | 3.83M 464.66% | |
net debt to ebitda | 3.87 - | 0.52 86.58% | 0.30 42.82% | 0.33 11.77% | 0.52 57.50% | 0.38 27.83% | 1.41 274.23% | 1.16 18.13% | 0.10 91.52% | 0.41 318.11% | |
net income per share | -1.17 - | -4.54 287.08% | -6.67 46.88% | -5.32 20.19% | -5.20 2.19% | -6.31 21.30% | -5.58 11.62% | -2.25 59.75% | -2.40 6.85% | -1.23 48.81% | |
operating cash flow per share | -1.25 - | -3.54 183.42% | -4.66 31.60% | -4.25 8.73% | -3.90 8.26% | -5.42 38.99% | -5.34 1.48% | -2.36 55.89% | -2.37 0.76% | -0.99 58.24% | |
payables turnover | 0.58 - | 0.14 75.67% | 0.05 61.30% | 0.04 - | |||||||
receivables turnover | 19.36 - | 17.08 11.74% | 12.11 29.09% | 13.35 10.17% | 8.61 35.49% | 5.52 35.89% | 8.08 46.42% | 2.94 63.60% | 25.02 750.50% | 8.80 64.84% | |
research and ddevelopement to revenue | 0.06 - | 0.69 1,053.65% | 1.24 79.08% | 1.85 49.30% | 2.68 44.70% | 4.83 80.35% | 6.75 39.59% | 5.77 14.46% | 6.54 13.32% | 13.18 101.41% | |
return on tangible assets | -0.11 - | -0.54 378.24% | -2.26 321.49% | -1.84 18.81% | -1.46 20.54% | -1.87 27.94% | -0.63 66.29% | -0.73 16.52% | -3.62 394.66% | -1.51 58.23% | |
revenue per share | 3.10 - | 1.69 45.48% | 2.37 40.29% | 1.72 27.57% | 1.24 28.00% | 0.83 33.03% | 0.56 31.82% | 0.25 55.93% | 0.22 13.21% | 0.07 69.49% | |
roe | -0.14 - | -0.68 402.22% | -2.77 306.36% | -3.35 20.88% | -4.29 28.13% | -8.20 91.25% | -0.85 89.59% | -0.91 6.92% | -20.80 2,178.92% | -4.22 79.73% | |
roic | -0.12 - | -0.56 387.77% | -2.77 394.38% | -3.35 20.90% | -4.31 28.50% | -7.23 67.79% | -0.84 88.43% | -0.90 7.61% | -21.02 2,233.61% | -2.94 86.02% | |
sales general and administrative to revenue | 0.98 - | 2.34 138.94% | 1.76 24.80% | 2.12 20.55% | 2.40 13.29% | 3.41 41.88% | 4.07 19.36% | 4.10 0.71% | 5.67 38.45% | 1.81 68.17% | |
shareholders equity per share | 8.65 - | 6.66 22.93% | 2.41 63.85% | 1.59 33.98% | 1.21 23.66% | 0.77 36.58% | 6.54 748.89% | 2.46 62.36% | 0.12 95.31% | 0.29 152.55% | |
stock based compensation to revenue | 0.10 - | 0.08 23.20% | 0.08 2.97% | 0.10 18.64% | 0.08 13.99% | 0.43 425.72% | 0.30 30.73% | 0.30 1.13% | 0.37 25.71% | 0.04 90.14% | |
tangible asset value | 4.37M - | 3.75M 14.29% | 1.53M 59.26% | 1.15M 24.93% | 992.52K 13.36% | 935.98K 5.70% | 10.45M 1,016.74% | 15.67M 49.93% | 734.54K 95.31% | 4.76M 547.61% | |
tangible book value per share | 8.65 - | 6.66 22.93% | 2.41 63.85% | 1.59 33.98% | 1.21 23.66% | 0.77 36.58% | 6.54 748.89% | 2.46 62.36% | 0.12 95.31% | 0.29 152.55% | |
working capital | 2.13M - | 1.51M 29.19% | 1.29M 14.45% | 952.75K 26.31% | 844.28K 11.39% | 816.95K 3.24% | 10.38M 1,170.30% | 15.61M 50.37% | 677.89K 95.66% | 3.85M 467.97% |
All numbers in USD (except ratios and percentages)